
Overview
Diagnostic imaging provider's Q4 revenue rose 14.8% yr/yr to $547.7 mln
Adjusted EPS for Q4 beat analyst expectations
Company anticipates 2026 revenue growth of 17%-19% in Imaging Center segment
Outlook
RadNet anticipates 2026 Imaging Center revenue growth of 17%-19%
Company expects 2026 Digital Health revenue to grow 46%-56%
RadNet sees 2026 Free Cash Flow growth of 29%-41%
Result Drivers
PROCEDURAL VOLUME GROWTH - Aggregate advanced imaging procedural volumes increased 14.1% in Q4 2025, with same-center volumes up 9.6%
DIGITAL HEALTH GROWTH - Digital Health segment revenue rose 48.2% in Q4 2025, driven by AI solutions and acquisitions
OPERATIONAL EFFICIENCIES - Focus on operational efficiencies and AI technology implementation contributed to margin improvement
Company press release: ID:nGNXb4s6tJ
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $547.70 mln |
|
Q4 Adjusted EPS | Beat | $0.23 | $0.20 (7 Analysts) |
Q4 EPS |
| -$0.01 |
|
Q4 Net Income |
| -$600,000 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for RadNet Inc is $91.50, about 31.1% above its February 27 closing price of $69.81
The stock recently traded at 90 times the next 12-month earnings vs. a P/E of 110 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.